BMO Capital Markets reaffirmed their hold rating on shares of HCP (NYSE:HCP) in a research note released on Wednesday morning. The brokerage currently has a $27.00 price target on the real estate investment trust’s stock.
Several other research firms have also recently issued reports on HCP. Cantor Fitzgerald initiated coverage on HCP in a research note on Tuesday, August 7th. They issued a neutral rating and a $28.00 price target for the company. Stifel Nicolaus set a $28.00 price target on HCP and gave the stock a buy rating in a research note on Friday, August 3rd. Zacks Investment Research raised HCP from a sell rating to a hold rating in a research note on Tuesday, August 7th. ValuEngine raised HCP from a sell rating to a hold rating in a research note on Thursday, July 5th. Finally, Bank of America increased their price target on HCP from $27.50 to $28.00 and gave the stock a buy rating in a research note on Monday, September 17th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus target price of $26.75.
NYSE:HCP opened at $27.60 on Wednesday. HCP has a 1 year low of $21.48 and a 1 year high of $28.18. The firm has a market capitalization of $12.97 billion, a PE ratio of 14.15, a price-to-earnings-growth ratio of 6.94 and a beta of 0.16. The company has a quick ratio of 0.51, a current ratio of 0.48 and a debt-to-equity ratio of 1.21.
HCP (NYSE:HCP) last released its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.10. HCP had a return on equity of 3.06% and a net margin of 9.16%. The company had revenue of $456.00 million during the quarter, compared to analysts’ expectations of $456.59 million. During the same quarter in the prior year, the business posted $0.48 earnings per share. The company’s revenue for the quarter was up .4% compared to the same quarter last year. As a group, sell-side analysts predict that HCP will post 1.82 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 20th. Stockholders of record on Monday, November 5th will be issued a $0.37 dividend. The ex-dividend date is Friday, November 2nd. This represents a $1.48 annualized dividend and a dividend yield of 5.36%. HCP’s dividend payout ratio (DPR) is 75.90%.
Several institutional investors have recently made changes to their positions in HCP. Millennium Management LLC acquired a new stake in shares of HCP in the first quarter valued at $7,672,000. Suntrust Banks Inc. lifted its holdings in shares of HCP by 31.5% during the first quarter. Suntrust Banks Inc. now owns 17,478 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 4,191 shares during the last quarter. DnB Asset Management AS lifted its holdings in shares of HCP by 7.0% during the second quarter. DnB Asset Management AS now owns 55,366 shares of the real estate investment trust’s stock valued at $1,430,000 after purchasing an additional 3,600 shares during the last quarter. IFM Investors Pty Ltd lifted its holdings in shares of HCP by 42.4% during the second quarter. IFM Investors Pty Ltd now owns 22,549 shares of the real estate investment trust’s stock valued at $582,000 after purchasing an additional 6,709 shares during the last quarter. Finally, Xact Kapitalforvaltning AB lifted its holdings in shares of HCP by 24.0% during the second quarter. Xact Kapitalforvaltning AB now owns 180,400 shares of the real estate investment trust’s stock valued at $4,658,000 after purchasing an additional 34,911 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Article: What is a Tariff?
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.